These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19020508)

  • 41. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):581-601, vii-viii. PubMed ID: 18775353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cardiometabolic syndrome in the adolescent.
    Gardner M; Gardner DW; Sowers JR
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arterial hypertension and obesity--a dangerous combination].
    Zakharieva S
    Vutr Boles; 1999; 31(1):28-32. PubMed ID: 10847146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial.
    McMillan-Price J; Petocz P; Atkinson F; O'neill K; Samman S; Steinbeck K; Caterson I; Brand-Miller J
    Arch Intern Med; 2006 Jul; 166(14):1466-75. PubMed ID: 16864756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular implications of obesity.
    Nichols N
    Can J Cardiovasc Nurs; 2006; 16(2):58-63. PubMed ID: 17153133
    [No Abstract]   [Full Text] [Related]  

  • 47. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.
    Benecke H; Topak H; von zur Mühlen A; Schuppert F
    Exp Clin Endocrinol Diabetes; 2000; 108(2):86-92. PubMed ID: 10826514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Weight loss reduces risk of developing cardiovascular disease (CVD)--need for effective weight loss strategies grows as prevalence of obesity increases.
    Cardiovasc J S Afr; 2001; 12(1):56-7. PubMed ID: 11474690
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of popular weight loss diets on cardiovascular risk reduction.
    Worel JN; Hayman LL
    J Cardiovasc Nurs; 2015; 30(3):184-5. PubMed ID: 25874668
    [No Abstract]   [Full Text] [Related]  

  • 50. Oxidative stress markers and cardiovascular disease: advantage of using these factors in combination with lifestyle factors for cardiovascular risk assessment.
    Kawada T
    Int J Cardiol; 2012 May; 157(1):119-20. PubMed ID: 22465344
    [No Abstract]   [Full Text] [Related]  

  • 51. The search for the perfect heart-healthy diet.
    Gau GT
    Mayo Clin Proc; 2003 Nov; 78(11):1329-30. PubMed ID: 14601689
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiovascular disease and fiber: is insulin resistance the missing link?
    Savaiano DA; Story JA
    Nutr Rev; 2000 Nov; 58(11):356-8. PubMed ID: 11140908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IGF-I: panacea or poison?
    LeRoith D
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4549-51. PubMed ID: 20926541
    [No Abstract]   [Full Text] [Related]  

  • 54. Weight cycling and cardiovascular risk in obese men and women.
    Phinney SD
    Am J Clin Nutr; 1992 Oct; 56(4):781-2. PubMed ID: 1414977
    [No Abstract]   [Full Text] [Related]  

  • 55. New insights into how adenovirus might lead to obesity: An oxidative stress theory.
    Waye MM
    Free Radic Res; 2011 Aug; 45(8):880-7. PubMed ID: 21615271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction: oxidation and inflammation, a molecular link between non-communicable diseases.
    Camps J; García-Heredia A
    Adv Exp Med Biol; 2014; 824():1-4. PubMed ID: 25038988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What are we trying to prevent by controlling hypertension?
    Oliver MF
    Am Heart J; 1987 Oct; 114(4 Pt 2):1011-3. PubMed ID: 3661381
    [No Abstract]   [Full Text] [Related]  

  • 58. "Obesity paradox" or "metabolically benign obesity"?
    Finelli C; Tarantino G
    Eat Weight Disord; 2013 Sep; 18(3):337-8. PubMed ID: 23888401
    [No Abstract]   [Full Text] [Related]  

  • 59. New insights into insulin resistance, cardiovascular diseases and oxidative stress: pathophysiological and clinical consequences.
    Victor VM
    Curr Pharm Des; 2013; 19(32):5661-2. PubMed ID: 23448494
    [No Abstract]   [Full Text] [Related]  

  • 60. Obesity paradox.
    Bosello O; Donataccio MP
    Eat Weight Disord; 2013 Dec; 18(4):447-8. PubMed ID: 24146302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.